Contract between two companies delayed earlier peanut-allergy treatment

A protracted legal battle between Tanox, Genentech and Novartis illustrates the difficulties sometimes faced by companies that enter into drug development partnerships. When a trial for a potential peanut-allergy drug was halted amid accusations it infringed on the agreement between the three companies, patients taking part in the trial were taken off the drug, though it was showing promise in treating allergies.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC